Cell therapy for fibrotic interstitial pulmonary disease: Experimental study

Microscopy Research and Technique

Volumn 74, Issue 10, 2011, Pages 957-962

  Cabral, Rosa M ^a   Branco, Érika ^b   Rizzo, Márcia dos S ^a   Ferreira, Guilherme J ^a   Gregores, Guilherme B ^c   Samoto, Vivian Y ^c   Stopiglia, Ângelo J ^c   Maiorka, Paulo C ^c   Fioretto, Emerson T ^d   Capelozzi, Vera L ^c   Borges, João B ^c   Gomes, Susimeire ^c   Beraldo, Marcelo A ^c   Carvalho, Carlos R R ^c   Miglino, Maria A ^c  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b Federal Rural University of Amazonia   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

Cell therapy; Fibrotic interstitial pulmonary disease; Histological changes in lung

Indexed keywords

BIOLOGICAL ORGANS; CELLS; COMPUTERIZED TOMOGRAPHY; CYTOLOGY; DISEASE CONTROL; PULMONARY DISEASES; SULFUR COMPOUNDS;

BONE MARROW; CELL THERAPY; FIBROTIC INTERSTITIAL PULMONARY DISEASE; HIGH-RESOLUTION COMPUTED TOMOGRAPHY; HISTOLOGICAL CHANGE IN LUNG; HISTOLOGICAL CHANGES; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; INTERSTITIALS; MONONUCLEAR CELLS;

HISTOLOGY;

ANIMALIA; SUIDAE;

EID: 80052433588     PISSN: 1059910X     EISSN: 10970029     Source Type: Journal    
DOI: 10.1002/jemt.20981     Document Type: Article

References (27)

1. Balazs G, Noma S, Khan A, Eacobacci T, Herman PG. 1994. Bleomycin-induced fibrosis in pigs: Evaluation with CT. Radiology 191: 269-272.
2. Bellini A, Mattoli S. 2007. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactiveand reparative fibroses. Lav Invest 87: 858-870.
3. Berend N, Feldsien D, Cederbaums D, Cherniack RM. 1985. Structure-function correlation of early stages of lung injury induced by intratracheal bleomycin in the rabbit. Am Rev Resp Dis 132: 582-589.
4. Coletta ENAM, Pereira CAC, Ferreira RG, Rubin AS, Vilella LS, Malheiros T, Stavale JN. 2003. Histological features and survival in idiopathic pulmonary fibrosis. J Pneumol 29: 371-378.
5. Cottin V, Capron F, Grenier P, Cordier JF. 2004. Idiopathic interstitial pneumonias; International multidisciplinary consensus classification by the American Thoracic Society and the European Respiratory Society. Clinico-pathological entities and diagnosis. Rev Mal Respir 21: 299-318.
6. Dooner M, Cerny J, Colvin G, Demers D, Pimentel J, Greer D, Abedi M, Mcauliffe C, Quesenberry P. 2004. Homing and conversion of murine hematopoietic stem cells to lung. Blood Cells Mol Dis 32: 47-55.
7. Dunsmore SE, Shapiro SD. 2004. The bone-marrow leaves its scar: New concepts in pulmonary fibrosis. J Clin Invest 113: 180-182.
8. Grande NR, Peão MND, As CM, Aguas AP. 1998. Lung fibrosis induced by Bleomycin: Structural changes and overview of recent advances. Scan Microsc 12: 487-494.
9. Gross TJ, Hunninghake GW. 2001. Idiopathic pulmonary fibrosis. N Engl J Med 345: 517-524.
10. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. 2004. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113: 243-252.
11. Kasper M, Bierhaus A, Whyte A, Binns RM, Schuh D, Muller M. 1996. Expression of CD454 isoforms during bleomycin-or radiation-induced pulmonary fibrosis in rats and mini-pigs. Histochem Cell Biol 105: 221-230.
12. Khubchandani KR, Snyder JM. 2001. Surfactant protein A (SP-A): The alveolus and beyond. FASEB J 15: 59-69.
13. Kotton DN, Fine A. 2008. Lung stem cells. Cell Tissue Res 331: 45-56.
14. Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC, Fine A. 2001. Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development 128: 5181-5188.
15. Kotton DN, Summer R, Fine A. 2004. Lung stem cells: New paradigms. Exp Hematol 32: 340-343.
16. Liem NT, Nakajima N, Phat LP, Sato Y, Thach HN, Hung PV, San LT, Katano H, Kumasaka T, Oka T, Kamachi S, Matsushita T, Sata T, Kudo K, Suzuki K. 2008. H5N1- Infected cells in lung with diffuse alveolar damage in exudative phase from a fatal case in Vietnam. Jpn J Infected Dis 61: 157-160.
17. Loebinger MR, Janes SM. 2007. Stem cells for lung disease. Chest 132: 279-285.
18. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE, Jr, Bradford WZ, Schwartz DA, Webb WR. 2005. High-resolution computed tomography in idiopathic pulmonary fibrosis: Diagnosis and prognosis. Am J Resp Critical Care Med 172: 488-493.
19. Manoury B, Nenan S, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V. 2005. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res 6: 1465-9921.
20. McCullough B, Collins JF, Johanson WG, Jr, Grover FL. 1978. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. JClin Invest 61: 79-88.
21. Moeller A, Askl K, Warburton D, Gauldie J, Kolb M. 2007. The Bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40: 362-382.
22. Moodley YP, Caterina P, Scaffidi AK, Misso NL, Papadimitriou JM, McAnulty RJ, Laurent GJ, Thompson PJ, Knight D.A. 2004. Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis. J Pathol 202: 486-495.
23. Ortiz LA, Gambelli F, Mcbride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. 2003. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411.
24. Parra ER, David YR, Costa LRS, Ab'saber A, Sousa R, Kairalla RA, Carvalho CRR. 2005. Heterogeneous remodeling of lung vessels in idiopathic pulmonary fibrosis. Lung 183: 291-230.
25. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. 2005. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Resp Cell Mol Biol 33: 145-152.
26. Ryu JH, Daniels CE, Hartman TE, Yi ES. 2007. Diagnosis of Interstitial Lung Diseases. Mayo Clin Proc 82: 976-986.
27. Serra AP, Parra ER, Eher E, Capelozzi VL. 2006. Nonhomogeneous immunostaining of hyaline membranes in different manifestations of diffuse alveolar damage. Clinics 61: 497-502.